AP-306 | m-entrepreneurship.com

Product Name :
AP-306

Search keywords :
SLC34A2

drugId :
null

Target Vo:
Sodium-dependent phosphate transport protein 2B

Target Vo Short Name :
NaPi-2b

Moa_Name:
Sodium-dependent phosphate transport protein 2B inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Chugai Pharmaceutical Co Ltd

Active Company_Name :
Alebund Pharmaceuticals (Hong Kong) Ltd

Active Indication_Name:
Nephrosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-AMPK alpha 1 (Ser496) Antibody (YA226)
Vimentin Antibody
YB1 Antibody: YB1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 36 kDa, targeting to YB1. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts